BPC-157 legal status checked country by country. FDA position, WADA rules, European regulations and import rules with primary source citations.
Ranked on the criteria below. Prices and ratings come from the merchant pages.
BPC-157 lyophilized vial from Peptide God, priced at $34.95.
Pre-mixed BPC-157 and TB-500 blend from PeptideGod. One vial for the wolverine stack.
BPC-157 10mg vial from Real Peptides with published lot COA and HPLC verification.
We look for a batch-level certificate of analysis published by the merchant.
Purity percentage and milligrams per vial as stated on the product page.
Clear research-use labeling, lot numbers and storage instructions.
Vials compared on price per milligram, not on sticker price.
BPC-157 is not approved for human use by the FDA, the EMA or any other national regulator. It is not a controlled substance. Selling it as a drug is illegal, but individual possession is not a federal crime. The rules depend on your country, your role and how you obtain it. This page tracks the legal status across major jurisdictions, updated with primary source citations.
The inquiry "is BPC-157 legal?" cannot be answered with a straightforward "yes" or "no." In fact, this substance lies at the crossroads of pharmaceutical control, customs regulations, regulatory provisions concerning sport activities and pharmacy acts. Whether BPC-157 is legal will depend on a number of variables, such as your role as a purchaser, seller, importer, the prescriber or user of the product.
BPC-157 is not a controlled substance under the DEA. It is not approved as a drug, supplement or food additive by the FDA. The FDA placed it in Category 2 (significant safety concerns) in September 2023; the nominations were withdrawn by April 2026. The Pharmacy Compounding Advisory Committee voted 8-6 in July 2026 to recommend inclusion on the 503A bulks list, but the FDA has not acted on this advisory vote. Between 2019 and 2026, the FDA sent warning letters to at least 11 companies selling or compounding BPC-157. Full US legal status
Australia classified BPC-157 as Schedule 4 (Prescription Only Medicine) under the Poisons Standard in June 2024. It was the first country to specifically schedule BPC-157. Possession without a valid prescription from an AHPRA-registered practitioner is a regulatory breach. Access is available through compounding pharmacies and the TGA's Special Access Scheme. Full Australia status
BPC-157 has no marketing authorization from the EMA or any member state. It is not a controlled substance in most EU countries. Selling it as a medicine without authorization is illegal. Buying it as a research chemical occupies a grey zone that varies by country. Germany enforces pharmaceutical law more strictly than the Netherlands. Full EU/UK status
BPC-157 has no MHRA licence. It is not a controlled substance under the Misuse of Drugs Act 1971 or the Psychoactive Substances Act 2016. Selling it as a research chemical for laboratory purposes is legal. Selling it with health claims would violate the Human Medicines Regulations 2012. Full UK status
| Jurisdiction | Approved Drug? | Controlled Substance? | Research Chemical Sale | Sports Ban? |
|---|---|---|---|---|
| United States | No | No | Grey zone | Yes (WADA/USADA) |
| Australia | No | Schedule 4 | Prescription required | Yes (WADA) |
| United Kingdom | No | No | Legal (no health claims) | Yes (WADA/UKAD) |
| Germany | No | No (not in BtMG) | Restricted; institutional exemption | Yes (WADA/NADA) |
| France | No | No | Unclear | Yes (WADA/AFLD) |
| Canada | No | No | Grey zone | Yes (WADA/CCES) |
Purchasing BPC-157 from a US research vendor is not a criminal act. It is also not clearly legal. The FDA has focused enforcement on sellers, not buyers. The risk for individual buyers is low but not zero. International orders carry additional customs risk. Buying guide
BPC-157 is prohibited by WADA under S0 (Non-Approved Substances) and has been explicitly named since 2022. All athletes subject to WADA, USADA, UKAD or any national anti-doping authority face sanctions. The standard first violation ban is four years. There is no TUE pathway for BPC-157. WADA rules
Physicians can prescribe BPC-157, but compounding pharmacies face regulatory risk using it as a bulk substance. The FDA has sent warning letters specifically for this violation. The PCAC's 8-6 vote to recommend inclusion is a positive signal, but the FDA has not acted yet. Prescription guide | Compounding rules
If BPC-157's legal status is a concern, regulated alternatives include telehealth peptide services, cosmetic copper peptides and FDA-approved peptide drugs. None replicate BPC-157's pharmacological profile, but they operate within clearer regulatory frameworks. Legal alternatives
BPC-157 is not a controlled substance and individual possession is not a crime. However, it is not an approved drug, and selling it as one is illegal. The legal status depends on how you obtain it and what you do with it. Full US breakdown.
No. BPC-157 has no FDA approval for any use. No company has filed a New Drug Application. The Pharmacy Compounding Advisory Committee voted 8-6 in July 2026 to recommend it for the compounding bulks list, but the FDA has not made a final decision. Full FDA record.
No. BPC-157 is on the WADA Prohibited List under S0 (Non-Approved Substances). A positive test carries a 2-4 year ban. There is no therapeutic use exemption pathway for unapproved substances. WADA details.
The substance does not feature on schedules of the Drug Enforcement Administration. So possession of the substance does not subject people to the legal issues faced by people keeping anabolic steroids and illegal substances.
In Australia, a prescription is necessary to get BPC-157 as of June 2024 (according to Schedule 4). Worldwide, the sale of the same without proper permission is illegal. In sports, it is banned under the WADA Code. Individual possession is regarded as a grey area in most countries rather than as an outright prohibition.
Chronological timeline of BPC-157 regulatory decisions. FDA actions, WADA listings, warning letters and compounding committee votes by date.
FDA warning letters sent to companies selling BPC-157 and other peptides. Violations cited, company responses and what the letters mean for the market.
BPC-157 and NCAA drug testing rules. Which banned substance categories apply, testing protocols and what a positive result means for college athletes.
Every guide and ranking on this site is checked by a named reviewer before it is published.